SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-08-05
👔
Nurix Therapeutics, Inc.
@NRIX_InsiderForm 4 Filing: Hansen Gwenn Sells $117,002.16 of $NRIX
INSIDER SALE
⚡ MATERIALITY: 5/10
corporate issuer
Nurix Therapeutics, Inc.
Ticker: $NRIX
Transaction Value
$117,002.16
Price/Share: $13.43
transaction date
2026-08-05
Shares: 8,712
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Hansen Gwenn, holds the title of Chief Scientific Officer at Nurix Therapeutics, Inc..
On 2026-08-05, the insider transacted 8,712 shares.The shares were transacted at a weighted average price of $13.43 per share, resulting in a total market-relevant value of $117,002.16.
Executive Summary Summary
Hansen Gwenn (Chief Scientific Officer) sold $117K of $NRIX
Post-Transaction Position: 117,227 shares
SEC Accession No: 0001817160-26-000017 (CIK: 1817160)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.